Janssen’s psoriasis drug shows promise for childhood diabetes
Type 1 diabetes accounts for approximately 10% of diabetes cases in the UK
Read Moreby Jen Brogan | Aug 7, 2024 | News | 0
Type 1 diabetes accounts for approximately 10% of diabetes cases in the UK
Read Moreby Jen Brogan | Nov 14, 2023 | News | 0
The projects will explore early-stage ideas at the frontiers of bioscience
Read Moreby Jen Brogan | Oct 27, 2023 | News | 0
Around 145,000 people in the UK are living with Parkinson’s disease
Read Moreby John Pinching | Jun 12, 2023 | News | 0
The treatment candidate, known as MDI-26478, is a positive allosteric modulator of the AMPA receptor
Read Moreby John Pinching | Feb 13, 2023 | News | 0
Partnership will focus on essential new therapies across neurodegenerative diseases
Read Moreby Anna Smith | Jan 2, 2019 | News | 0
Researchers from Cardiff University have discovered a protein driving aggressive breast cancer, which they say could be targeted for developing new and improved therapies.
Read Moreby Selina McKee | Nov 20, 2018 | News | 0
Cardiff University has formed a drug discovery collaboration with Takeda to identify new approaches for treating schizophrenia and other psychiatric disorders.
Read More





PharmaTimes Media Ltd.
44 Maiden Lane
Covent Garden
London
WC2E 7LN
E: editorial@pharmatimes.com
E: subscriptions@pharmatimes.com
T: +44 (0)20 7240 6999
